CNBC World

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

Shares in humanoid robot firm Unitree surge 600% on Chinese stock market debutWorldPing
The Guardian

Shares in humanoid robot firm Unitree surge 600% on Chinese stock market debut

Company’s robots have gained global fame via videos of them performing martial arts and as dancers for pop stars Unitree, the world’s biggest humanoid robot maker, has made a spectacular entry on to China’s stock market, with its shares surging by mo…

Brief by WorldPing · Original reporting by The Guardian